Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature

被引：2
|
作者：
Gautret, Philippe [1 ,2 ]
Van Thuan Hoang [1 ,2 ,3 ]
Honore, Stephane [4 ,5 ]
Roussel, Yanis [1 ,6 ]
Million, Matthieu [1 ,6 ]
Lagier, Jean-Christophe [1 ,6 ]
Raoult, Didier [1 ,6 ]
机构：
[1] IHU Mediterranee Infect, Marseille, France
[2] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France
[3] Thai Binh Univ Med & Pharm, Thai Binh, Vietnam
[4] Hop La Timone, AP HM, Serv Pharm, Marseille, France
[5] Aix Marseille Univ, Lab Pharmacie Clin, Marseille, France
[6] Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2021年 / 57卷 / 01期
关键词：
D O I：
10.1016/j.ijantimicag.2020.106241
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
    Varisco, Tyler J.
    Johnson, Michael L.
    Thornton, Douglas
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 373 - 373
  • [32] Cardiovascular Safety of Hydroxychloroquine-Azithromycin in 424 COVID-19 Patients
    Million, Matthieu
    Lagier, Jean-Christophe
    Hourdain, Jerome
    Franceschi, Frederic
    Deharo, Jean-Claude
    Parola, Philippe
    Brouqui, Philippe
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [33] COVID-19 AND QTC: IS HYDROXYCHLOROQUINE WORTH THE RISK? A REVIEW OF QT PROLONGATION IN HOSPITALISED COVID-19 PATIENTS TREATED WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN
    Pollock, A.
    Kumar, R.
    Devitt, P.
    Kent, B.
    Daly, C.
    HEART, 2020, 106 : A1 - A1
  • [34] Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection
    Giaime, Philippe
    Guenoun, Maxime
    Pedinielli, Nathalie
    Narbonne, Herve
    Bergounioux, Jean-Philippe
    Solas, Caroline
    Guilhaumou, Romain
    Sampol, Jerome
    Ollier, Jacques
    Sichez, Helene
    Serveaux, Marianne
    Brunner, Flora
    Bataille, Stanislas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (08) : 1346 - 1353
  • [35] Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
    O'Connell, Thomas F.
    Bradley, Christopher J.
    Abbas, Amr E.
    Williamson, Brian D.
    Rusia, Akash
    Tawney, Adam M.
    Gaines, Rick
    Schott, Jason
    Dmitrienko, Alex
    Haines, David E.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2021, 7 (01) : 16 - 25
  • [36] Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
    Gautret, Philippe
    Honore, Stephane
    Lagier, Jean-Christophe
    Raoult, Didier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (01)
  • [37] Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective
    Kapoor, Aditya
    Sahu, Ankit Kumar
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2021, 7 (01) : 78 - 82
  • [38] Hydroxychloroquine, azithromycin and ivermectin: treatments not recommended for Covid-19
    Buxeraud, Jacques
    ACTUALITES PHARMACEUTIQUES, 2023, 62 (627): : 4 - 4
  • [39] Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
    Albani, Filippo
    Fusina, Federica
    Giovannini, Alessia
    Ferretti, Pierluigi
    Granato, Anna
    Prezioso, Chiara
    Divizia, Danilo
    Sabaini, Alessandra
    Marri, Marco
    Malpetti, Elena
    Natalini, Giuseppe
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 10
  • [40] Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
    El Ouarradi, Amal
    Abdeladim, Salma
    Oualim, Sara
    Filali, Rita Aniq
    Bensahi, Ilham
    Elharass, Mahassine
    Hafid, Sara
    Tazi, Hamza
    Naitlhou, Abdelhamid
    Bouaiti, El Arbi
    Moustaghfir, Abdelhamid
    Sabry, Mohamed
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2020, 32 (03) : 350 - 357
12345